Last week, the FDA advisory panel rejected Pfizer's proposal for a booster shot for the general US population, but approved one for older and high-risk Americans. Reuters
Last week, the FDA advisory panel rejected Pfizer's proposal for a booster shot for the general US population, but approved one for older and high-risk Americans. Reuters